Panion & BF Biotech Inc - Asset Resilience Ratio

Latest as of September 2023: -0.52%

Panion & BF Biotech Inc (1760) has an Asset Resilience Ratio of -0.52% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

NT$-16.14 Million

≈ $-508.47K USD Cash + Short-term Investments

Total Assets

NT$3.08 Billion

≈ $97.00 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2021)

This chart shows how Panion & BF Biotech Inc's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Panion & BF Biotech Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Panion & BF Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 1760 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$-16.14 Million	-0.52%
Total Liquid Assets	NT$-16.14 Million	-0.52%

Asset Resilience Insights

Limited Liquidity: Panion & BF Biotech Inc maintains only -0.52% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Panion & BF Biotech Inc Industry Peers by Asset Resilience Ratio

Compare Panion & BF Biotech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
ALTEOGEN Inc KQ:196170	Biotechnology	55.57%
Apogee Therapeutics, Inc. Common Stock NASDAQ:APGE	Biotechnology	47.01%
Definium Therapeutics, Inc. NASDAQ:DFTX	Biotechnology	34.94%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Galapagos N.V. AS:GLPG	Biotechnology	86.45%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Inventiva S.A PA:IVA	Biotechnology	52.73%

Annual Asset Resilience Ratio for Panion & BF Biotech Inc (2009–2021)

The table below shows the annual Asset Resilience Ratio data for Panion & BF Biotech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	2.36%	NT$69.79 Million ≈ $2.20 Million	NT$2.95 Billion ≈ $93.04 Million	-0.76pp
2020-12-31	3.13%	NT$96.13 Million ≈ $3.03 Million	NT$3.07 Billion ≈ $96.85 Million	-2.12pp
2019-12-31	5.25%	NT$100.32 Million ≈ $3.16 Million	NT$1.91 Billion ≈ $60.25 Million	+1.39pp
2018-12-31	3.86%	NT$70.74 Million ≈ $2.23 Million	NT$1.83 Billion ≈ $57.81 Million	+2.53pp
2017-12-31	1.32%	NT$16.49 Million ≈ $519.40K	NT$1.25 Billion ≈ $39.30 Million	-0.49pp
2016-12-31	1.81%	NT$21.59 Million ≈ $680.14K	NT$1.19 Billion ≈ $37.53 Million	-0.25pp
2015-12-31	2.06%	NT$24.24 Million ≈ $763.69K	NT$1.18 Billion ≈ $37.03 Million	-0.22pp
2014-12-31	2.28%	NT$25.25 Million ≈ $795.54K	NT$1.11 Billion ≈ $34.91 Million	+1.37pp
2013-12-31	0.91%	NT$9.10 Million ≈ $286.70K	NT$1.00 Billion ≈ $31.52 Million	-0.60pp
2012-12-31	1.51%	NT$13.96 Million ≈ $439.69K	NT$924.20 Million ≈ $29.12 Million	-0.06pp
2011-12-31	1.58%	NT$14.71 Million ≈ $463.51K	NT$934.09 Million ≈ $29.43 Million	+0.72pp
2010-12-31	0.86%	NT$7.41 Million ≈ $233.46K	NT$861.72 Million ≈ $27.15 Million	-0.74pp
2009-12-31	1.60%	NT$14.00 Million ≈ $441.20K	NT$873.43 Million ≈ $27.52 Million	--

pp = percentage points

About Panion & BF Biotech Inc

TW:1760 Taiwan Biotechnology

Market Cap

$158.29 Million

NT$5.02 Billion TWD

Market Cap Rank

#17379 Global

#866 in Taiwan

Share Price

NT$58.60

Change (1 day)

+1.03%

52-Week Range

NT$58.00 - NT$73.20

All Time High

NT$228.22